Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: Updated efficacy and safety from the randomized phase III study 309/KEYNOTE-775 Journal Article

   

Authors:	Makker, V.; Colombo, N.; Herráez, A. C.; Monk, B. J.; Mackay, H.; Santin, A. D.; Miller, D. S.; Moore, R. G.; Baron-Hay, S.; Ray-Coquard, I.; Ushijima, K.; Yonemori, K.; Kim, Y. M.; Guerra Alia, E. M.; Sanli, U. A.; Bird, S.; Orlowski, R.; McKenzie, J.; Okpara, C.; Barresi, G.
Article Title:	Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: Updated efficacy and safety from the randomized phase III study 309/KEYNOTE-775
Journal Title:	Journal of Clinical Oncology
Volume:	41
Issue:	16
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2023-06-01
Start Page:	2904
End Page:	2910
Language:	English
DOI:	10.1200/jco.22.02152
PROVIDER:	EBSCOhost
PROVIDER:	cinahl
PUBMED:	37058687
PMCID:	PMC10414727
DOI/URL:	https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,shib&db=cin20&AN=163946163&authtype=sso&custid=s2915669&site=ehost-live&scope=site&custid=s2915669
Notes:	MSK corresponding author is Vicky Makker -- Source: Cinahl

https://synapse.mskcc.org/synapse/works/has_related_data_chk/206967